Asset Details
Do you wish to reserve the book?
Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England
Do you wish to request the book?
Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England
2011
Overview
This study updates previous work on modelling the incidence of varicella and Herpes Zoster (HZ) following the introduction of childhood vaccination. The updated model includes new data on age-specific contact patterns, as well as data on the efficacy of zoster vaccination in the elderly and allows for HZ among vaccinees. The current study also looks at two-dose varicella childhood programmes, and assesses the combined impact of varicella vaccination in childhood and zoster vaccination of the elderly. The results suggest that a two-dose schedule is likely to reduce the incidence of varicella to very low levels, provided first dose coverage is around 90% and second dose coverage is in excess of 70%. Single dose varicella vaccination programmes are expected to result in large numbers of breakthrough cases. Childhood vaccination is expected to increase the incidence of zoster for more than 40 years after introduction of the programme, the magnitude of this increase being influenced primarily by the duration of boosting following exposure to the varicella zoster virus. Though this increase in zoster incidence can be partly offset by vaccination of the elderly, the effectiveness of this combined strategy is limited, as much of the increase occurs in those adults too young to be vaccinated. Childhood vaccination at intermediate levels of coverage (70% and 60% for first and second dose coverage respectively) is expected to lead to an increase in adult varicella. At high coverage (90% and 80% coverage) this is unlikely to be the case. These results will be used to inform a cost-effectiveness analysis of combined varicella and zoster vaccination programmes.
Publisher
Elsevier Ltd,Elsevier,Elsevier Limited
Subject
/ Adult
/ Age
/ Aged
/ Chickenpox - prevention & control
/ Chickenpox Vaccine - administration & dosage
/ Chickenpox Vaccine - immunology
/ Child
/ elderly
/ England
/ Female
/ Herpes Zoster - epidemiology
/ Herpes Zoster - prevention & control
/ Humans
/ Infant
/ Infectious disease modelling
/ Male
/ Ordinary differential equations
/ Sciences biologiques et medicales
/ Sciences biologiques fondamentales et appliquees. Psychologie
/ Shingles
/ Vaccines
/ Vaccins, immunsérums, immunoglobulines et anticorps monoclonaux thérapeutiques en général
